Biomarin Pharmaceutical (BMRN) Shares Outstanding (Diluted) (2009 - 2026)

Biomarin Pharmaceutical (BMRN) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Biomarin Pharmaceutical 13.04 Bn 12.16 Bn 786.91 Mn 194.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 194.47 Mn
Mar 31, 2026 197.67 Mn
Dec 31, 2025 197.39 Mn
Sep 30, 2025 192.03 Mn
Jun 30, 2025 197.09 Mn
Mar 31, 2025 196.47 Mn
Dec 31, 2024 196.71 Mn
Sep 30, 2024 197.15 Mn
Jun 30, 2024 200.51 Mn
Mar 31, 2024 199.26 Mn
Dec 31, 2023 191.60 Mn
Sep 30, 2023 191.17 Mn
Jun 30, 2023 195.00 Mn
Mar 31, 2023 194.36 Mn
Dec 31, 2022 188.96 Mn
Sep 30, 2022 185.60 Mn
Jun 30, 2022 187.45 Mn
Mar 31, 2022 194.89 Mn
Dec 31, 2021 182.85 Mn
Sep 30, 2021 183.21 Mn